Introducing the 7th production line, the innovative BOV Completion of the 3rd expansion introducing 3 new production lines Establishing Photo Voltaic green alternative energy source International Red Cross accreditation and shipping to Geneva 6 new in-licensing agreements Penetrating new geographies (CIS, North & Central Africa, NGO)
Our Journey
1989
API Founding
API was founded by Dr. Mohammad Al-Atrash in 1989 as one of the first pharmaceutical companies in the MENA region to pioneer the production of niche branded generics in the therapeutic areas of Ophthalmology, ENT, Respiratory, & Dermatology
1992
Started Production
Started production of sterile eye drops and expanded operations into Saudi Arabia, the biggest market in the Middle East
1999
Completed the 2 nd expansion
Completed the 2 nd expansion resulting in the launch of 3 new production lines including the highly innovative eye ointment line in addition to oral preparations and dermatology lines
Aug. 2005
Beginning of a New Era
Beginning of a New Era in management of the company
Launch of the Nasal Spray production line.
Total revenue was doubled in the course of 3 years.
Company converted from LLC to PSC paving the way for capital increase
2012
CE mark registration
- CE mark registration for Nasal Spray line.
- E&Y Jordan Nomination.
- Production Capacity Tripled.
- Warehouses Expanded.
2016
Introducing the 7th production line
2020
Stayed resilient across an unprecedented pandemic
Stayed resilient across an unprecedented pandemic and overcame COVID-19.
Was able to achieve double-digit growth Completed Production area renovation project.
Purchased new 6,000m² land for future expansion Increased capacity of the Sterile Eye Drops Line Established Cosmetics Line & Oral Gel Line
2021 - Present
Agreements
Obtained USFDA Drug Establishment
Registration and Signed a tech transfer agreement with Hikma and
Registration of the first multidose preservative free eye drops in the region